Zusammenfassung
Hintergrund
Die aseptische Osteonekrose (ON) des Erwachsenen stellt ein Krankheitsbild ungeklärter Ätiologie dar. Da eine kurative Behandlung dieser Erkrankung häufig nur in Frühstadien gelingt, kommt der Schmerztherapie eine zentrale Behandlungsrolle zu.
Methode
Bewährte und neue Therapieoptionen für die ON sowie eigene Therapieresultate nach i.v.-Applikation des Prostazyklinanalogons Iloprost werden mit entsprechenden Studien in der Literatur verglichen.
Ergebnisse
Neben der Behandlung mit NSRA und Opioiden sind operative „core decompression“, vasoaktive Medikamente sowie hyperbare Oxygenierung wirksam. Eine 5-tägige Applikation von Iloprost ergab eine hochsignifikante Schmerzreduktion.
Schlussfolgerung
Die symptomatische Therapie ist in allen ON-Stadien indiziert, die kurative in den Stadien I und frühem Stadium II. Bei Progredienz ist im Falle der großen Gelenke der frühzeitige endoprothetische Gelenkersatz indiziert, um Sekundärschäden zu vermeiden. Neben dem Einsatz vasoaktiver Substanzen könnte ein weiterer kurativer Therapieansatz in mesenchymalen Stammzellen bestehen.
Abstract
Background
Adult aseptic osteonecrosis (ON) represents a clinical picture with unexplained etiology. Since curative treatment of this disease often succeeds only in the early stage, pain therapy plays an important role in the treatment process.
Method
We compared established and novel treatment options for ON as well as our own results after i.v. administration of the prostacyclin analogue iloprost with corresponding studies in the literature.
Results
In addition to treatment with nonsteroidal antirheumatic agents and opioids, surgical “core decompression,” vasoactive medications, and hyperbaric oxygenation are effective. Treatment with iloprost for 5 days resulted in highly significant pain reduction.
Conclusion
Symptomatic treatment is indicated in all stages of ON and curative treatment in stage I and early stage II. In cases of disease progression in the large joints, early endoprosthetic replacement is indicated to avoid secondary damage. In addition to employing vasoactive substances, a further curative treatment approach could be the use of mesenchymal stem cells.
Literatur
Aaron RK, Lennox D, Stuhlberg BN (1997) The natural history of osteonecrosis of the femoral head and risk factors for radpid progression. In: Urbaniak JR, Jones JP (eds) Osteonecrosis: etiology, diagnosis and treatment. Am Acad Orthop Surg 261–265
Adam G, Keulers O. Forst J, Neuerburg M, Kilbinger RW, Günther RW (1995) MR-Tomographie avaskulärer Knochennekrosen: Primärbefunde und Verlaufsbeobachtungen nach Markraumdekompression. Fortschr Röntgenstr 164:330–334
Aigner N, Petje G, Steinboeck G, Schneider W, Krasny C, Landsiedl F (2001) Treatment of bone-marrow edema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method. J Bone Joint Surg [Br] 83(6):855–858
Aigner N, Petje G, Schneider W, Krasny C, Grill F, Landsiedl F (2002) Juvenile bone-marrow edema of the acetabulum treated by iloprost. J Bone Joint Surg [Br] 84(7):1050–1052
Aigner N, Meizer R, Stolz G, Petje G, Krasny C, Landsiedl F, Steinboeck G (2003) Iloprost for the treatment of bone marrow edema in the hindfoot. Foot Ankle Clin 8(4):683–693
Arlet J, Mazieres B, Thiechart, M, Vallieres G (1990) The effect of i.v. injection of naftidrofuryl on the intramedullary pressure in patients with osteonecrosis of the femoral head. In: Arlet J, Mazieres B (eds) Bone cirulation and bone necrosis. Springer, Berlin Heidelberg New York, pp 405–406
Ashamalla HL, Thom SR, Goldwein JW (1996) Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children. The University of Pennsylvania experience. Cancer 77(11):2407–2412
Astrand J, Aspenberg P (2002) Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Dis 3(1):19
Auwerx J, Schoonjans K, Fruchart JC, Staels B (1996) Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects. J Atheroscler Thromb 3(2):81–89
Bernbeck B, Krauth KA, Scherer A, Engelbrecht V, Gobel U (2002) Aseptic osteonecrosis in a child with nephroblastoma healed by hyperbaric oxygen therapy. Med Pediatr Oncol 39(1):47–48
Bird AD, Telfer ABM (1965) Effect of hyperbaric oxygen on limb circulation. Lancet 1:355–356
Bizot P, Nizard R, Banallec L, Sedel L (2000) Results of ceramic on ceramic bearings in patients younger than 40 years of age. Clin Orthop 79:68–76
Boerema I, Meijne NG, Brummelkamp WK, Bouma S, Mensch MH, Kamermans F, Stern Hanf M, Van Aalderen W (1960) Life without blood. A study of the influence of high atmospheric pressure and hypothermia on dilution of the blood. J Cardiovasc Surg 1:133–146
Bolland MJ, Hood G, Bastin ST, King AR, Grey A (2004) Bilateral femoral head osteonecrosis after septic shock and multiorgan failure. J Bone Miner Res 19(3):517–520
Bouyer C (1968) Treatment of painful osseous crises of sickle cell anemia with an arteriolar vasodilator. Ann Soc Belg Med Trop 48(6):597–605
Buchman AL (1999) Bones and Crohn’s: problems and solutions. Inflamm Bowel Dis 5(3):212–227
Chan YS, Hsih CH (2000) Bipolar versus total hip arthroplasty for hip osteonecrosis in the same patient. Clin Orthop 379:169–177
Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E (2003) The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication. Kardiol Pol 59(9):197–204
D’Antonio JA, Capello WN, Manley MT, Feinberg J (1997) Hydroxyapatite coated implants. Total hip arthroplasty in the young patient and patients with avascular necrosis. Clin Orthop 344:124–38
Den Heijer M, Koster T, Blom HJ (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759–762
Disch AC, Matziolis G, Reinke P, Perka C (2004) Intravenous Iloprost treatment for severe bone pain caused by sickle cell crisis. Thromb Haemost 91(5):1047–1049
Drescher W, Schneider T, Becker C, Hobolth L, Ruther W, Bunger C, Hansen ES (2002) Effect of methylprednisolone on reperfusion after femoral head ischemia. Clin Orthop 402:270–277
Drescher W, Weigert KP, Bunger MH, Ingerslev J, Bunger C, Hansen ES (2004) Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs. J Orthop Res 22(3):501–508
Durst HB, Blatter G, Kuster MS (2002) Osteonecrosis of the humeral head after extracorporeal shock-wave lithotripsy. J Bone Joint Surg [Br] 84(5):744–746
Engelbrecht V, Scherer A, Bruder M, Korholz D, Mödder U (2000) MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 172(4):336–341
Fenollosa J, Seminario P, Montijano C (2000) Ceramic hip prosthesis in young patients. Clin Orthop 379:55–67
Ficat RP, Arlet J (1980) Functional investigation of bone under normal conditions. In: Hungerford DS (ed) Ischemia and necrosis of bone. Williams & Wilkins, Baltimore, pp 29–52
Ficat RP (1985) Idiopathic bone necrosis of the femoral head. J Bone Joint Surg [Br] 67(1):3–9
Fink B, Schneider T, Conrad S, Jaeger M, Protzen M, Ruther W (2002) The thrust plate prosthesis in patients with aseptic osteonecrosis of the femoral head. Arch Orthop Trauma Surg 122(9–10):499–505
Glueck CJ, Freiberg R, Gruppo R et al. (1997) Thrombophilia and hypofibrinolysis: reversible pathogenetic etiologies of osteonecrosis in adults and children. In: Urbaniak JR, Jones TP jr (eds) Osteonecrosis: etiology, diagnosis, and treatment. Am Acad Orthop Surg 105–110
Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P (1997) Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop 334:43–56
Glueck CJ, McMahon RE, Bouquot JE, Tracy T, Sieve-Smith L, Wang P (1998) A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85(1):64–73
Glueck CJ, Phillips HG, Cameron D, Wang P (2001) Estrogen replacement in a protein S deficient patient leads to diarrhea, hyperglucagonemia, and osteonecrosis. JOP 2(5):323–329
Glueck CJ, Freiberg RA, Wang P (2003) Role of thrombosis in osteonecrosis. Curr Hematol Rep 2(5):417–422
Guan YF, Breyer MD (2001) Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Internat 60(1):14–30
Gauthier VJ, Barbosa LM (1994) Bone pain in transplant recipients responsive to calcium channel blockers. Ann Int Med 121(11):863–865
Hardy P, Haab F, Leparc JM, Lortat-Jacob A, Benoit J (1998) Aseptic avascular necrosis of the femoral condyles in renal transplant patients: clinical and radiological aspects on 69 knees. Knee Surg Sports Traumatol Arthrosc 6(4):209–214
Harper PG, Trask C, Souhami RL (1984) Avascular necrosis of bone caused by combination chemotherapy without corticosteroids. Br Med J (Clin Res Ed) 288(6413):267–268
Hasegawa Y, Sakano S, Iwase T, Iwasada S, Torii S, Iwata H (2003) Pedicle bone grafting versus transtrochanteric rotational osteotomy for avascular necrosis of the femoral head. J Bone Joint Surg [Br] 85:191–198
Hattrup SJ (1998) Indications, technique, and results of shoulder arthroplasty in osteonecrosis. Orthop Clin North Am 29(3):445–451
Hattrup SJ, Cofield RH (2000) Osteonecrosis of the humeral head: results of replacement. J Shoulder Elbow Surg 9(3):177–182
Heaf JG (2003) Bone disease after renal transplantation. Transplantation 75(3):315–325
Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop 405:14–23
Hernigou P, Bachir D, Galacteros F (2003) The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg [Am] 85(3):500–504
Hofmann S, Mazières B (2000) Osteonecrosis: natural course and conservative treatment. Orthopäde 29(5):403–410
Horiuchi H, Saito N, Kobayashi S, Ota H, Taketomi T, Takaoka K (2002) Avascular necrosis of the femoral head in a patient with Fabry’s disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum 46(7):1922–1925
Huang GS, Chan WP, Chang YC, Chang CY, Chen CY, Yu JS (2003) MR imaging of bone marrow edema and joint effusion in patients with osteonecrosis of the femoral head: relationship to pain. AJR Am J Roentgenol 181(2):545–549
Hungerford DS, Mont MA (1998) The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis. J Bone Joint Surg [Am] 80(5):765–766
Imhoff AB, Öttl GM, Burkart A, Traub S (1999) Osteochondrale autologe Transplantation an verschiedenen Gelenken. Orthopäde 28:33–44
Inoue S, Horii M, Asano T, Fujioka M, Ogura T, Shibatani M, Kim WC, Nakagawa M, Tanaka T, Hirota Y, Kubo T (2003) Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation. J Orthop Sci 8(6):751–756
Ito H, Matsuno T, Kaneda K (1999) Prognosis of early stage avascular necrosis of the femoral head. Clin Orthop 358:149–157
Izbicka E, Dunstan C, Esparza J, Jacobs C, Sabatini M, Mundy GR (1993) A human amniotic tumor with induces new bone formation in vivo produces a growth regulatory activity in vitro for osteoblasts identified as basic fibroblast gwoth factor (FGF). J Bone Miner Res 8 [suppl]:93
Jäger M, Thorey F, Wild A, Voede M, Krauspe R (2003) Osteonekrosen bei Morbus Adamantiades-Behcet: Diagnostik, Therapie und Verlauf. Z Rheumatol 62(4):390–394
Jäger M, Wild A, Krauspe R (2003) Osteonecrosis und HELLP-Syndrom. Z Geburtsh Neonatol 207(6):213–219
Jäger M, Endres S, Wilke S (2004) Hüftgelenkersatz im Kindes-, Jugend- und frühen Erwachsenenalter: Eine Literaturübersicht. Z Orthop Ihre Grenzgeb 142(2):194–212
Jakob RP, Franz T, Gaultier E, Mainil-Varlet P (2002) Autologous osteochondral grafting in the knee: indication, results and reflections. Clin Orthop 401:170–184
Jergesen, Khan AS (1997) The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis. J Bone Joint Surg [Am] 79:359–363
Jones JP (2000) Epidemiologische Risikofaktoren für die nichttraumatische Osteonekrose. Orthopäde 29:370–379
Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Gleuck CJ (2003) Procoagulants and osteonecrosis. J Rheumatol 30(4):783
Judet H, Gilbert A (1991) Long term results of free vascularized fibular grafting for femoral head necrosis. Clin Orthop 386:114–119
Justen HP, Muller-Ladner U, Leeb I, Lang B, Wessinghage D (1998) Surgical treatment of aseptic bone necroses of both knee joints in antiphospholipid antibody syndrome (APL) by synovectomy, arthrolysis and arthroplasty. Z Rheumatol 57(4):222–226
Kataoka Y, Hasegawa Y, Iwata H, Matsuda T, Genda E, Miura T, Takahashi H (1992) Effect of hyperbaric oxygenation on femoral head osteonecrosis in spontaneously hypertensive rats. Acta Orthop Scand 63(5):527–530
Kim YM, Rhyu KH, Lee SH, Kim HJ (2003) Can osteonecrosis of the femoral head be recurrent. Clin Orthop 406:123–128
LaPorte DM, Mont MA, Mohan V, Jones LC, Hungerford DS (1998) Multifocal steonecrosis. J Rheumatol 25(10):1968–1974
Landgraf H, Ehrly AM (1981) Wirkungen einer Clofibrat-induzierten Senkung der Fibrinogenkonzentration im Blut bei peripheren arteriellen Durchblutungsstörungen. In: Mahler F, Nachbur B (Hrsg) Zerebrale Ischämie. Huber, Bern, S 277–279
Laroche M, Jacquemier JM, Montane de la Roque P, Arlet J, Mazieres B (1990) Nifedipine per os relieves the pain caused by osteonecrosis of the femur head. Rev Rhum Mal Osteoartic 57(9):669–670
Laroche M (2002) Intraosseous circulation from physiology to disease. Joint Bone Spine 69(3):262–269
Le Meur Y, Moesch C, Rince M, Aldigier JC, Leroux-Robert C (1995) Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate. Nephrol Dial Transplant 10(9):1751–1755
Lee CH, Olson P, Evans RM (2003) Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144(6):2201–2207
Leschke M, Klimek W, Jung F (2003) Rheological determinants of end-organ damage. Internist (Berl) 44(7):853–863
Levin D, Norman D, Zinman C, Rubinstein L, Sabo E, Misselevich I, Reis D, Boss J (1999) Treatment of experimental avascular necrosis of the femoral head with hyperbaric oxygen in rats: histological evaluation of the femoral head during the early phase of the reparative process. Exp Mol Pathol 67(2):99–108
L’Insalata JC, Pagnani MJ, Warren RF, Dines DM (1996) Humeral head osteonecrosis: clinical course and radiographic predictors of outcome. J Shoulder Elbow Surg 5(5):355–361
Li X, Cui Q, Kao C, Wang GJ, Balian G (2003) Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33(4):652–659
Little DG, Peat RA, Mcevoy A, Williams PR, Smith EJ, Baldock PA (2003) Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 18(11):2016–2022
Ludwig J, Lauber S, Lauber HJ, Dreisilker U, Raedel R, Hotzinger H (2001) High-energy shock wave treatment of femoral head necrosis in adults. Clin Orthop 387:119–126
Marconi A, Darquenne S, Boulmerka A, Mosnier M, D’Alessio P (2003) Naftidrofuryl-driven regulation of endothelial ICAM-1 involves nitric oxide. Free Radic Biol Med 34(5):616–625
Mazierés B (1994) Bone morphogenetic protein and bone necrosis: a perspective. ARCO News 5:3–5
McCarthy J, Puri L, Barsoum W, Lee J, Laker M, Cooke P (2003) Articular cartilage changes in avascular necrosis: an arthroscopic evaluation. Clin Orthop 406:64–70
Meyer D, Behrens G, Stoll M, Schmidt RE (2000) Osteonecrosis: a rare complication of HIV infection. Association with certain risk factors. MMW Fortschr Med 142 [suppl 1]:64–67
Mihalko WM, Balos L, Santilli M, Mindell ER (2003) Osteonecrosis after powered core decompression. Clin Orthop 412:77–83
Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, Mican JM, Liu S, Gerber LH, Blackwelder WC, Falloon J, Davey RT, Polis MA, Walker RE, Lane HC, Kovacs JA (2002) High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137(1):17–25
Miskew DB, Goldflies ML (1980) Atraumatic avascular necrosis of the talus associated with hyperuricemia. Clin Orthop 148:156–159
Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg [Am] 77(3):459–474
Mont MA, Tomek IM, Hungerford DS (1997) Core decompression for avascular necrosis of the distal femur: long term followup. Clin Orthop 334:124–130
Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH (1998) Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop 355 [suppl]:314–335
Mont MA, Baumgarten KM, Rifai A, Bluemke DA, Jones LC, Hungerford DS (2000) Atraumatic osteonecrosis of the knee. J Bone Joint Surg [Am] 82(9):1279–1290
Mont MA, Rifai A, Baumgarten KM, Sheldon M, Hungerford DS (2002) Total knee arthroplasty for osteonecrosis. J Bone Joint Surg [Am] 84-A(4):599–603
Moskal JT, Topping RE, Franklin LL (1997) Hypercholesterolemia: an association with osteonecrosis of the femoral head. Am J Orthop 26(9):609–612
Mundy GR (1996) Regulation of bone formation by bone morphogenietic protein and other growth factors. Clin Orthop 323:24–28
Nercessian OA, Wu WH, Sarkissian H (2001) Clinical and radiographic results of cementless AML total hip arthroplasty in young patients. J Arthroplasty 16:312–316
Niinikoski J, Hunt TK (1996) Oxygen and healing wounds: tissue-bone repair enhancement. In: Oriani G, Marroni A, Wattel F (eds) Handbook on hyperbaric medicine. Springer, Berlin Heidelberg New York, pp 485–507
Nylander G, Lewis D, Nordström H, Larsson J (1985) Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 76:596–601
O‘Driscoll SW, Fitzsimmons JS (2001) The role of periosteum in cartilage repair. Clin Orthop 391-S:190–207
Ohzono K, Saito M, Sugano N, Takaoka K, Ono K (1992) The fate of nontraumatic avascular necrosis of the femoral head. A radiologic classification to formulate prognosis. Clin Orthop 277:73–78
Pape D, Seil R, Fritsch E, Rupp S, Kohn D (2002) Prevalence of spontaneous osteonecrosis of the medial femoral condyle in elderly patients. Knee Surg Sports Traumatol Arthrosc 10(4):233–240
Park J, Jun J, Kim Y, Lee J, Kim C, Hahn S (2002) Osteonecrosis of the hip in patients with aplastic anemia. J Korean Med Sci 17(6):806–810
Pescin B, Shupak A, Levin D, Norman D, Jacob Z, Boss JF, Misselevich I, Reis DN, Zinman C (2001) Effects of non-weight bearing and hyperbaric oxygen therapy in vascular deprivation-induced osteonecrosis of the rat femoral head. Undersea Hyperb Med 28(4):187–194
Petje G, Radler C, Aigner N, Kriegs-Au G, Ganger R, Grill F (2002) Aseptic osteonecrosis in childhood: diagnosis and treatment. Orthopäde 31(10):1027–1038
Plenk H, Hofmann S, Breitenseher M, Urban M (2000) Pathomorphologische Aspekte und Reparaturmechanismen der Femurkopfosteonekrose. Orthopäde 29:389–402
Pola R, Gaetani E, Flex A, Aprahamian TR, Bosch-Marce M, Losordo DW, Smith RC, Pola P (2004) Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors. J Mol Cell Cardiol 36(3):363–370
Raab P, Kuhl J, Krauspe R (1997) Multifokale Osteonekrosen bei Kindern und Jugendlichen nach Polychemotherapie. Z Orthop 135:444–450
Reis D, Schwartz O, Militianu D, Ramon Y, Levin D, Norman D, Melamed Y, Shupak A, Goldsher D, Zinman C (2003) Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. J Bone Joint Surg [Br] 85:371–375
Rubinstein RA, Beals RK (1993) The results of treatment of posttraumatic avascular necrosis of the femoral head in young adults: report of 31 patients. Contemp Orthop 27:527–532
Russo S, Galsso O, Gigliotti S (1999) Shock wave therapy for the treatment of nip necrosis. ESMST/2nd Internat. Congress of the Euopean Society for Musculoskeltal Shock Wave Therapy, London (Proceedings)
Ryu JS, Kim JS, Moon DH, Kim SM, Shin MJ, Chang JS, Park SK, Han DJ, Lee HK (2002) Bone SPECT is more sensitive than MRI in the detection of early osteonecrosis of the femoral head after renal transplantation. J Nucl Med 43(8):1006–1011
Saltzman CL (1999) Total ankle arthroplasty: state of the art. Instr Course Lect 48:263–268
Scherer A, Engelbrecht V, Bernbeck B, May P, Willers R, Gobel U, Modder U (2000) MRI evaluation of aseptic osteonecrosis in children over the course of hyperbaric oxygen therapy. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 172(10):798–801
Scherer A, Engelbrecht V, Krauth KA, Bernbeck B, Reinwand U, Willers R, Göbel U, Mödder U (2001) MRT-Verlaufsbeurteilung aseptischer Knochennekrosen (AON) bei Kindern mit chemotherapierter maligner Grunderkrankung. Klin Pädiatr 213:56–62
Scotter E, Moody A (1988) Dysbaric osteonecrosis (Caisson disease). Radiogr Today 54(617):41–43
Scribner AN, Troia-Cancio PV, Cox BA, Marcantonio D, Hamid F, Keiser P, Levi M, Allen B, Murphy K, Jones RE, Skiest DJ (2000) Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr 25:19–25
Scully SP, Rizk SW, Seaber AV, Urbaniak JR (1995) Augmentation of subchondral bone formation in AVN with rhBMP-2. Trans ORS 20:495
Simank HG, Brocai DR, Strauch K, Lukoschek M (1999) Core decompression in osteonecrosis of the femoral head: risk-factor-dependent outcome evaluation using survivorship analysis. Int Orthop 23(3):154–159
Simank HG, Herold F, Schneider M, Maedler U, Ries R, Sergi C (2004) Das Wachstumsfaktorkomposit aus GDF-5 und mineralisiertem Kollagen verbessert die Ausheilung einer Hüftkopfnekrose. Eine Untersuchung im Tiermodell. Orthopäde 33(1):68–75
Skyhar MJ, Hargens AR, Strauss MB, Gershuni DH, Hart GB, Akeson WH (1986) Hyperbaris oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. J Bone Joint Surg [Am] 68:1218–1224
Steinberg ME, Brighton CT, Hayken GD, Tooze SE, Steinberg DR (1985) Electrical stimulation in the treatment of osteonecrosis of the femoral head—a 1-year follow-up. Orthop Clin North Am 16(4):747–756
Steinberg ME (1988) Management of avascular necrosis of the femoral head-an overview. Instr Course Lect 37:41–50
Steinberg ME, Hayken GD, Steinberg DR (1995) A quantitative system for staging avascular necrosis. J Bone Joint Surg [Br] 77(1):34–41
Steinberg ME, Larcom PG, Strafford B, Hosick WB, Corces A, Band RE, Hartman KE (2001) Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop 386:71–78
Strauss MB, Hargens AR, Gershuni DH, Greenberg DA, Crenshaw AG, Hart, GB, Akeson WH (1983) Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. J Bone Joint Surg [Am] 65:656–662
Strauss MB, Dvorak T (1999) Femoral head necrosis and hyperbaric oxygen therapy. In: Kindwall EP, Whelan HT (eds) Hyperbaric medicine practice, 2nd edn. Best Publishing, pp 909–927
Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB (2001) Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 19(12):3066–3072
Stuhlberg BN, Davis AW, Bauer TW, Levine M, Easley K (1991) Osteonecrosis of the femoral head: a postpective randomized treatment protocol. Clin Orthop 268:140–151
Stuhlberg BN (2003) Osteonecrosis: what to do? J Arthroplasty 18(3) [suppl 1]:74–79
Stukenborg-Colsman C, Wirth CJ (2003) Die Osteonekrose des Kniegelenkes: Pathophysiologie, Klinik und aktuelle Therapie. Arthroskopie 16:8–14
Tooke SM, Amstutz HC, Dlaunay C (1987) Hemiresurfacing for femoral head osteonecrosis. J Arthroplasty 2:125–133
Trancik T, Lunceford E, Strum D (1990) The effect of electrical stimulation on osteonecrosis of the femoral head. Clin Orthop 256:120–124
Wang GJ, Rawles JG, Hubbard SL, Stamp WG (1983) Steroid-induced femoral head pressure changes and their response to lipid-clearing agents. Clin Orthop 174:298–302
Wang KZ, Mao LZ, Hu CG (1994) Experimental study on mechanism of steroid-induced avascular necrosis of femoral head. Zhonghua Wai Ke Za Zhi 32(9):515–517
Wang GJ, Qui Qu, Balian G (2000) The pathogenesis and prevention of steroid induced osteonecrosis. Clin Orthop 370:295–310
Wang Y, Li Y, Mao K, Li J, Cui Q, Wang GJ (2003) Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop. 410:213–224
Watson RM, Roach NA, Dalinka MK (2004) Avascular necrosis and bone marrow edema syndrome. Radiol Clin North Am 42(1):207–219
Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B (2002) Skeletal aspects of Gaucher disease: a review. Br J Radiol 75 [suppl 1]:A2–12
Werner A, Jäger M, Schmitz H, Krauspe R (2003) Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood. Klin Padiatr 215(6):332–337
Winet H, Bao JY, Moffat R (1990) A control model for tibial cortex neovascularization in the bone chamber. J Bone Miner Res 5:19–30
Wirth CJ, Stukenborg-Colsman C, Wefer A (1988) Osteonekrose des Femurkondylus. Orthopäde 27:501–507
Wolfe CJ, Taylor-Butler KL (2000) Avascular necrosis. A case history and literature review. Arch Fam Med 9(3):291–294
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jäger, M., Werner, A., Lentrodt, S. et al. Schmerztherapie bei nichtjuvenilen, aseptischen Osteonekrosen. Schmerz 18, 481–491 (2004). https://doi.org/10.1007/s00482-004-0356-9
Issue Date:
DOI: https://doi.org/10.1007/s00482-004-0356-9